Your browser doesn't support javascript.
loading
Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.
Mol Cell Proteomics ; 19(1): 223, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31894100